发明名称 |
INDUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) BY THE SERINE/THREONINE PROTEIN KINASE AKT |
摘要 |
<p>The present invention relates to methods and compositions for therapeutic angiogenesis. More especially, this invention is directed to induction of vascular endothelial growth factor (VEGF) expression by the serine/threonine protein kinase AKT. Preferably, the compositions and methods according to the invention comprise a nucleic acid encoding AKT, and administration thereof.</p> |
申请公布号 |
SI20978(A) |
申请公布日期 |
2003.02.28 |
申请号 |
SI20000020029 |
申请日期 |
2000.06.01 |
申请人 |
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
发明人 |
GUO KUN;IVASHCHENKO YURI;CLARK KENNETH |
分类号 |
C12N15/09;A61K31/7088;A61K33/24;A61K35/76;A61K38/00;A61K38/04;A61K38/22;A61K38/45;A61K38/46;A61K39/395;A61K45/06;A61K48/00;A61P9/10;C12N9/12;(IPC1-7):C12N9/12;A61K31/708 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|